A new study led by Stephen D. Nimer, M.D., director of Sylvester Comprehensive Cancer Center, part of the University of Miami ...

Current approaches in bioengineering are synthesized and methods for their implementation are suggested for the induction and modulation of trained immunity in the treatment of human diseases.

A Ph.D. graduate student in biomolecular engineering at UC Santa Cruz, with a background in computer science and mathematics, ...

Elegen’s cell-free ENFINIA DNA with an unparalleled combination of speed, length, accuracy and complexity integrates seamlessly with Nutcracker Therapeutics’ existing RNA-based PCT development ...

DNA makes RNA, RNA makes protein, protein makes phenotype—was the guiding framework for understanding inheritance and disease. This model explained classic Mendelian traits, such as how single DNA ...

replaced a faulty letter in KJ’s DNA with the correct one that now lets him eat some protein. KJ’s treatment represents the next phase of CRISPR-based therapies. While CRISPR treatments have been ...

New method maps RNA in cells at native locations, revealing spatial responses to signals and offering insight into disease mechanisms and treatment targets.

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 trial.

LINE-1, a "jumping gene" making up 20% of the genome, invades DNA during cell division using protein-RNA clusters, offering insights into genome evolution and disease. Viruses are masters of hijacking ...

Researchers discovered a previously unknown function of RNA, potentially opening the door to new ways to treat cancer and neurodegenerative diseases.

Updated data from 17 patients show BEAM-101's efficacy in sickle cell disease, achieving significant HbF induction and reduced HbS.